This study compared differences in weight loss, comorbidity resolution and complications and reoperations between a recently established sleeve gastrectomy (SG) and prior laparoscopic Rox-en-Y gastric bypass (RYGB).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Weight loss
Timeframe: after 6 weeks
Weight loss
Timeframe: after 1 year
Weight loss
Timeframe: after 2 years
Changes in Diabetes
Timeframe: after 1 year
Changes in Diabetes
Timeframe: after 2 years
Changes in Hypertension
Timeframe: after 1 year
Changes in Hypertension
Timeframe: after 2 years
Changes in hypertriglyceridemia (plasma-level >1.7 mmol/l)
Timeframe: after 1 year
Changes in hypertriglyceridemia (plasma-level >1.7 mmol/l)
Timeframe: after 2 year
Changes in Hypercholesterolemia (LDL-C > 3.0 mmol/L and/or HDL-C < 1.0 mmol/L).
Timeframe: after 1 years
Changes in Hypercholesterolemia (LDL-C > 3.0 mmol/L and/or HDL-C < 1.0 mmol/L).
Timeframe: after 2 years
Duration of surgery
Timeframe: From the start of the operation until completion, in average 62 minutes
Duration of hospital stay
Timeframe: From time of operation until discharge, in average 1.7 days
Early complications
Timeframe: At six weeks
Early reoperations
Timeframe: At six weeks
Late complications
Timeframe: From six weeks until 2 years from operation
Late reoperations
Timeframe: From six weeks until 2 years from operation